Profilo
Lana Elizabeth Janes is the founder of Abdera Therapeutics, Inc. Current jobs include Director at LifeSciences British Columbia, Director at Microdermics, Inc. since 2018, Independent Director at Centre For Probe Development & Commercialization since 2021, Director at Phoenix Molecular Designs Ltd., and Venture Partner at adMare Bioinnovations.
Former job includes Chief Patent Officer & SVP-Intellectual Property at QLT, Inc. Education includes undergraduate studies at Harvard University and a doctorate from McGill University.
Posizioni attive di Lana Janes
| Società | Posizione | Inizio |
|---|---|---|
Phoenix Molecular Designs Ltd.
Phoenix Molecular Designs Ltd. Miscellaneous Commercial ServicesCommercial Services Engages in research and development of drugs to treat triple negative breast cancer | Direttore/Membro del Consiglio | - |
Microdermics, Inc.
Microdermics, Inc. Medical SpecialtiesHealth Technology Develops novel hollow microneedles | Direttore/Membro del Consiglio | 01/01/2018 |
LifeSciences British Columbia
LifeSciences British Columbia BiotechnologyHealth Technology Supports and represents the biotechnology and greater life sciences community of Britsh Columbia | Direttore/Membro del Consiglio | - |
adMare Bioinnovations
adMare Bioinnovations Miscellaneous Commercial ServicesCommercial Services adMare Bioinnovations engages in the provision of research for its academic and biotech partners. The company was founded in 2011 and is headquartered in Vancouver, Canada. | Corporate Officer/Principal | - |
Centre For Probe Development & Commercialization
Centre For Probe Development & Commercialization Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes radiopharmaceuticals for early diagnosis and treatment of diseases | Direttore/Membro del Consiglio | 17/06/2021 |
Abdera Therapeutics, Inc.
Abdera Therapeutics, Inc. Packaged SoftwareTechnology Services Develops precision radiotherapeutics platform | Fondatore | - |
Precedenti posizioni note di Lana Janes
| Società | Posizione | Fine |
|---|---|---|
QLT, Inc.
QLT, Inc. Miscellaneous Commercial ServicesCommercial Services Develops and markets ocular products | Corporate Officer/Principal | - |
Formazione di Lana Janes
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 9 |
|---|---|
QLT, Inc.
QLT, Inc. Miscellaneous Commercial ServicesCommercial Services Develops and markets ocular products | Commercial Services |
Harvard University
Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
McGill University
McGill University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
LifeSciences British Columbia
LifeSciences British Columbia BiotechnologyHealth Technology Supports and represents the biotechnology and greater life sciences community of Britsh Columbia | Health Technology |
Microdermics, Inc.
Microdermics, Inc. Medical SpecialtiesHealth Technology Develops novel hollow microneedles | Health Technology |
Centre For Probe Development & Commercialization
Centre For Probe Development & Commercialization Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes radiopharmaceuticals for early diagnosis and treatment of diseases | Health Technology |
Phoenix Molecular Designs Ltd.
Phoenix Molecular Designs Ltd. Miscellaneous Commercial ServicesCommercial Services Engages in research and development of drugs to treat triple negative breast cancer | Commercial Services |
adMare Bioinnovations
adMare Bioinnovations Miscellaneous Commercial ServicesCommercial Services adMare Bioinnovations engages in the provision of research for its academic and biotech partners. The company was founded in 2011 and is headquartered in Vancouver, Canada. | Commercial Services |
Abdera Therapeutics, Inc.
Abdera Therapeutics, Inc. Packaged SoftwareTechnology Services Develops precision radiotherapeutics platform | Technology Services |
















